References:
1. Haupt HM, Moore GW, Bauer TW, Hutchins GM. The lung in sickle cell disease. Chest 1982;81(3):332-337.
2. Sylvester KP, Patey RA, Kassim Z, Rafferty GF, Rees D, Thein SL, Greenough A. Lung gas transfer in children with sickle cell anaemia. Respiratory physiology & neurobiology 2007;158(1):70-74.
3. Miller GJ, Serjeant GR. An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax 1971;26(3):309-315.
4. Setty BY, Stuart MJ, Dampier C, Brodecki D, Allen JL. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. The Lancet 2003;362(9394):1450-1455.
5. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease–life expectancy and risk factors for early death. New England Journal of Medicine 1994;330(23):1639-1644.
6. Mondal P, Stefek B, Sinharoy A, Sankoorikal B-J, Abu-Hasan M, Aluquin V. The association of nocturnal hypoxia and an echocardiographic measure of pulmonary hypertension in children with sickle cell disease. Pediatric Research 2019;85(4):506-510.
7. Chambellan A, Dirou S, Ricolleau B, Graveleau J, Masseau A. The value of diffusing capacity for nitric oxide and carbon monoxide in sickle cell disease. Eur Respiratory Soc; 2015.
8. Ogilvie C, Forster R, Blakemore WS, Morton J. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. The Journal of clinical investigation 1957;36(1):1-17.
9. Cotton D, Graham B. Effect of ventilation and diffusion nonuniformity on DLCO (exhaled) in a lung model. Journal of Applied Physiology 1980;48(4):648-656.
10. Dinakara P, Blumenthal W, Johnston R, Kauffman L, Solnick P. The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation. American Review of Respiratory Disease 1970;102(6):965-969.
11. Lacedonia D, Carpagnano GE, Galgano G, Schino P, Correale M, Brunetti ND, Ventura V, Di Biase M, Barbaro MPF. Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension. Eur Respiratory Soc; 2016.
12. Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, Silver R, Fischer A, Hinchcliff ME, Varga J. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. 2014. Elsevier. p 55-62.
13. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell anemia. American journal of respiratory and critical care medicine 2006;173(11):1264-1269.
14. Wall MA, Platt OS, Strieder DJ. Lung function in children with sickle cell anemia. American Review of Respiratory Disease 1979;120(1):210-214.
15. Matheson MC, Raven J, Johns DP, Abramson MJ, Walters EH. Associations between reduced diffusing capacity and airflow obstruction in community-based subjects. Respiratory medicine 2007;101(8):1730-1737.
16. Mondal P, Yirinec A, Midya V, Sankoorikal BJ, Smink G, Khokhar A, Abu‐Hasan M, Bascom R. Diagnostic value of spirometry vs impulse oscillometry: A comparative study in children with sickle cell disease. Pediatric pulmonology 2019;54(9):1422-1430.
17. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. The Journal of pediatrics 2001;138(2):188-192.
18. Biltagi MA, Bediwy AS, Toema O, Saeed NK. Pulmonary Functions in Children and Adolescents with Sickle Cell Disease. Pediatric Pulmonology 2020.
19. Macintyre N, Crapo R, Viegi G, Johnson D, Van der Grinten C, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. European Respiratory Journal 2005;26(4):720-735.
20. Larsen GL, Morgan W, Heldt GP, Mauger DT, Boehmer SJ, Chinchilli VM, Lemanske Jr RF, Martinez F, Strunk RC, Szefler SJ. Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. Journal of Allergy and Clinical Immunology 2009;123(4):861-867. e1.
21. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. Br Med J (Clin Res Ed) 1982;285(6342):633-635.
22. Hoth KF, Zimmerman ME, Meschede KA, Arnedt JT, Aloia MS. Obstructive sleep apnea. Sleep and Breathing 2013;17(2):811-817.
23. Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, Krishnamurti L. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatric blood & cancer 2006;47(7):907-913.
24. Bishara AJ, Hittner JB. Reducing bias and error in the correlation coefficient due to nonnormality. Educational and psychological measurement 2015;75(5):785-804.
25. Chen T, Guestrin C. Xgboost: A scalable tree boosting system. 2016. p 785-794.
26. Willen SM, Cohen R, Rodeghier M, Kirkham F, Redline SS, Rosen C, Kirkby J, DeBaun MR. Age is a predictor of a small decrease in lung function in children with sickle cell anemia. American journal of hematology 2018;93(3):408-415.
27. Chen L, Gong J, Matta E, Morrone K, Manwani D, Rastogi D, De A. Pulmonary disease burden in Hispanic and non‐Hispanic children with sickle cell disease. Pediatric Pulmonology 2020.
28. McLaren A, Klingel M, Behera S, Odame I, Kirby-Allen M, Grasemann H. Effect of hydroxyurea therapy on pulmonary function in children with sickle cell anemia. American Journal of Respiratory and Critical Care Medicine 2017;195(5):689-691.
29. Knight-Madden J, Forrester T, Lewis N, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60(3):206-210.
30. Sheather S. A modern approach to regression with R. Springer Science & Business Media; 2009.
31. Moreno JJM, Pol AP, Abad AS, Blasco BC. Using the R-MAPE index as a resistant measure of forecast accuracy. Psicothema 2013;25(4):500-506.
32. Wong T-T. Performance evaluation of classification algorithms by k-fold and leave-one-out cross validation. Pattern Recognition 2015;48(9):2839-2846.
33. Sylvester KP, Patey R, Milligan P, Dick M, Rafferty G, Rees D, Thein S, Greenough A. Pulmonary function abnormalities in children with sickle cell disease. Thorax 2004;59(1):67-70.
34. Semenova E, Kameneva M, Tishkov A, Trofimov V, Novikova L. Relationship the impulse oscillometry parameters and the lung damage in idiopathic pulmonary fibrosis patients. Eur Respiratory Soc; 2013.
35. Mehrad B, Burdick MD, Wandersee NJ, Shahir KS, Zhang L, Simpson PM, Strieter RM, Field JJ. Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease. Blood advances 2017;1(24):2217-2224.
36. Anthi A, Machado RF, Jison ML, Taveira-DaSilva AM, Rubin LJ, Hunter L, Hunter CJ, Coles W, Nichols J, Avila NA. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. American journal of respiratory and critical care medicine 2007;175(12):1272-1279.
37. Sylvester KP, Patey RA, Milligan P, Rafferty GF, Broughton S, Rees D, Thein SL, Greenough A. Impact of acute chest syndrome on lung function of children with sickle cell disease. The Journal of pediatrics 2006;149(1):17-22.
38. Chen G, Zhang D, Fuchs TA, Manwani D, Wagner DD, Frenette PS. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood 2014;123(24):3818-3827.
39. Zhang D, Xu C, Manwani D, Frenette PS. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood 2016;127(7):801-809.
40. Neas LM, Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of US adults. American journal of respiratory and critical care medicine 1996;153(2):656-664.